Acellular pertussis vaccines [5]

New England Journal of Medicine

Volumn 334, Issue 23, 1996, Pages 1547-1548

  Poltera, A A ^a   Tamburlini, G ^a   Materassi, P ^a   Decker, M D ^a   Edwards, K M ^a  

^a Berna Biotech AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA VACCINE; PERTUSSIS VACCINE; TETANUS TOXOID; BACTERIAL ANTIGEN;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MIXTURE; HUMAN; IMMUNOGENICITY; LETTER; MULTICENTER STUDY; PERTUSSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VACCINATION; VACCINE PRODUCTION; BORDETELLA PERTUSSIS; IMMUNOLOGY; NOTE; TREATMENT OUTCOME; ECONOMICS;

ANTIGENS, BACTERIAL; BORDETELLA PERTUSSIS; HUMANS; PERTUSSIS VACCINE; TREATMENT OUTCOME; WHOOPING COUGH;

EID: 0030006646     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199606063342317     Document Type: Letter

References (0)